Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 19, 2003

View Archived Issues

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Adventrx Pharmaceuticals

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Avidex

Prous Science DailyDrugNews and LifeSci Channel announce highlights from Rodman & Renshaw Techvest

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Avant Immunotherapeutics

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: BioCryst

Sleep-promoting effects of gaboxadol, a selective GABA-A receptor agonist, in rats

HCT-1026 and ibuprofen reduce resiniferatoxin-induced bladder hyperactivity in rats

Anandamide and oleamide increase food intake in rats

CB1 antagonists and their use reported by Sanofi-Synthelabo researchers

Kyowa Hakko and Millennium present new chemokine CXCR3 modulators

New cathepsin K inhibitors prepared and tested by GSK scientists

Novel cytokine production inhibitors covered by Boehringer Ingelheim patent

Axxima claims novel inhibitors of M. tuberculosis protein kinase PknG

New antidiabetic agent from plant origin identified by Indian researchers

Almirall Prodesfarma presents new muscarinic M3 antagonists in a recent patent

Novel 5-HT and/or dopamine receptor ligands discovered by Sepracor team

Access files OraDisc A NDA

Fast track designation for C31G vaginal gel

Boehringer and TeGenero partner for production of CD28-SuperMAB

deCODE acquires Bayer compound for heart attack prevention

New Zealand phase II trial for AVAC in pediatric atopic dermatitis

Genmab and ACE BioSciences identify first target in collaboration

MGI and Helsinn expand North American Aloxi agreement

MBI-594AN shows efficacy in phase IIb acne study

Thalidomide approved for multiple myeloma and ENL in Australia

Italian phase III trial for ADI in liver cancer

DES may facilitate repair of damaged nerve cells

Atherosclerosis regression with an apo A-I mimetic in acute coronary syndrome patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...